OR WAIT null SECS
September 16, 2010
Bristol-Myers Squibb (New York) has agreed to acquire the biopharmaceutical company ZymoGenetics (Seattle) for an aggregate purchase price of $885 million or $735 million net of cash.
The generic-drug company Actavis (Hafnarfjordur, Iceland) is considering acquiring a 51% stake in the biopharmaceutical company BioPartners Holdings (Barr, Switzerland) from Bioton, a Polish biotechnology company.
September 09, 2010
Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.
The Society for Chemical Manufacturers and Affiliates (SOCMA) issued recommendations relating to disclosure of confidential business information (CBI) in response to Environmental Protection Agency's (EPA) decision to limit CBI claims on chemical identity under the Toxic Substances Control Act (TSCA).
September 02, 2010
Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.
A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.
New data provide insight into pharma-industry professionals' daily lives.
September 01, 2010
The current trend in the pharmaceutical industry for the manufacture of small-molecule therapeutic agents is moving toward continuous flow processes. This article is part of a special issue on APIs.
The author presents recent developments in simulated moving-bed chromatography in production of active pharmaceutical ingredients and intermediates. This article is part of a special issue on APIs.
